Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression

被引：0

作者：

Robert Küffner

Neta Zach

Raquel Norel

Johann Hawe

David Schoenfeld

Liuxia Wang

Guang Li

Lilly Fang

Lester Mackey

Orla Hardiman

Merit Cudkowicz

Alexander Sherman

Gokhan Ertaylan

Moritz Grosse-Wentrup

Torsten Hothorn

Jules van Ligtenberg

Jakob H Macke

Timm Meyer

Bernhard Schölkopf

Linh Tran

Rubio Vaughan

Gustavo Stolovitzky

Melanie L Leitner

机构：

[1] Institute of Bioinformatics and Systems Biology,Department of Informatics

[2] German Research Center for Environmental Health,Department of Statistics

[3] Ludwig-Maximilians-University,Department of Neuroscience

[4] Prize4Life,undefined

[5] Tel Aviv,undefined

[6] Israel and Cambridge,undefined

[7] Massachusetts,undefined

[8] USA.,undefined

[9] IBM T.J. Watson Research Center,undefined

[10] Yorktown Heights,undefined

[11] MGH Biostatistics Center,undefined

[12] Massachusetts General Hospital,undefined

[13] Harvard Medical School,undefined

[14] Sentrana Inc.,undefined

[15] Latham&Watkins LLP,undefined

[16] Stanford University,undefined

[17] Beaumont Hospital and Trinity College Dublin,undefined

[18] Neurological Clinical Research Institute,undefined

[19] Massachusetts General Hospital,undefined

[20] Luxembourg Centre for Systems Biomedicine,undefined

[21] University of Luxembourg,undefined

[22] Max Planck Institute for Intelligent Systems,undefined

[23] Institute of Social- and Preventive Medicine,undefined

[24] University of Zürich,undefined

[25] Orca XL Problem Solvers,undefined

[26] Max Planck Institute for Biological Cybernetics and Bernstein Center for Computational Neuroscience,undefined

[27] Berkeley School of Public Health,undefined

[28] University of California,undefined

[29] ALS Innovation Hub,undefined

[30] Biogen Idec,undefined

来源：

Nature Biotechnology | 2015年 / 33卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

An open competition to predict the progression of amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig's disease) disease from the largest database of ALS clinical trial data yields potential new biomarkers and algorithms that outperform human clinicians.

引用

页码：51 / 57

页数：6

共 50 条

[1] Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression
Kueffner, Robert
Zach, Neta
Norel, Raquel
Hawe, Johann
Schoenfeld, David
Wang, Liuxia
Li, Guang
Fang, Lilly
Mackey, Lester
Hardiman, Orla
Cudkowicz, Merit
Sherman, Alexander
Ertaylan, Gokhan
Grosse-Wentrup, Moritz
Hothorn, Torsten
van Ligtenberg, Jules
Macke, Jakob H.
Meyer, Timm
Schoelkopf, Bernhard
Tran, Linh
Vaughan, Rubio
Stolovitzky, Gustavo
Leitner, Melanie L.
NATURE BIOTECHNOLOGY, 2015, 33 (01) : 51 - U292
[2] Identification of novel protein biomarkers that predict amyotrophic lateral sclerosis clinical progression
Pasinetti, GM
Ho, L
Brown, RH
Cudkowicz, ME
NEUROLOGY, 2004, 62 (07) : A85 - A85
[3] Amyotrophic lateral sclerosis biomarkers may predict disease progression
Su, X. W.
Simmons, Z.
Mitchell, R. M.
Kong, L.
Stephens, H. E.
Connor, J. R.
NEURODEGENERATIVE DISEASE MANAGEMENT, 2014, 4 (01) : 6 - 6
[4] A clinical trial of verapamil in amyotrophic lateral sclerosis
Miller, RG
Smith, SA
Murphy, JR
Brinkmann, JR
Graves, J
Mendoza, M
Sands, ML
Ringel, SP
MUSCLE & NERVE, 1996, 19 (04) : 511 - 515
[5] A clinical trial of dextromethorphan in amyotrophic lateral sclerosis
Gredal, O
Werdelin, L
Bak, S
Christensen, PB
Boysen, G
Kristensen, MO
Jespersen, JH
Regeur, L
Hinge, HH
Jensen, TS
ACTA NEUROLOGICA SCANDINAVICA, 1997, 96 (01): : 8 - 13
[6] Clinical Measures of Disease Progression in Amyotrophic Lateral Sclerosis
Rutkove, Seward B.
NEUROTHERAPEUTICS, 2015, 12 (02) : 384 - 393
[7] Clinical and neurophysiological evaluation of progression in amyotrophic lateral sclerosis
de Carvalho, M
Scotto, M
Lopes, A
Swash, M
MUSCLE & NERVE, 2003, 28 (05) : 630 - 633
[8] Clinical Measures of Disease Progression in Amyotrophic Lateral Sclerosis
Seward B. Rutkove
Neurotherapeutics, 2015, 12 : 384 - 393
[9] Prognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: validation and implications for clinical trial design and analysis
Benatar, Michael
Macklin, Eric A.
Malaspina, Andrea
Rogers, Mary-Louise
Hornstein, Eran
Lombardi, Vittoria
Renfrey, Danielle
Shepheard, Stephanie
Magen, Iddo
Cohen, Yahel
Granit, Volkan
Statland, Jeffrey M.
Heckmann, Jeannine M.
Rademakers, Rosa
McHutchison, Caroline A.
Petrucelli, Leonard
McMillan, Corey T.
Wuu, Joanne
EBIOMEDICINE, 2024, 108
[10] Validation of an Amyotrophic Lateral Sclerosis Staging System Using Clinical Trial Data
Jones, Ashley
Balendra, Rubika
McCrone, Paul
Turner, Martin
Leigh, Nigel
Al-Chalabi, Ammar
NEUROLOGY, 2013, 80

← 1 2 3 4 5 →